Background Treatment of diabetic neuropathic pain does not change the natural history of
neuropathy. Improved glycemic control is the recommended treatment in these cases, given …

Neuropathic pain in diabetics is characterized by both hyperalgesia and allodynia. This is
attributed to both uncontrolled glycemia and the further complications which it leads to. We …

Objective Diabetic neuropathy (DN) is the most common complication of diabetes and pain
is one of the main symptoms of diabetic neuropathy, however, currently available drugs are …

Neuropathic pain in diabetics is characterized by both hyperalgesia and allodynia. This is
attributed to both uncontrolled glycemia and the further complications which it leads to. We …

Studies suggest that inflammation is a key factor in the pathogenesis of diabetes mellitus.
Pro-inflammatory cytokines, such as IL-6 and TNF-alpha, are produced by adipose tissue in …

Neuropathic pain in diabetics is characterized by both hyperalgesia and allodynia. This is
attributed to both uncontrolled glycemia and the further complications which it leads to. We …

Background and Objective: Our previous study demonstrated that consistent treatment of
oral cilostazol was effective in reducing levels of painful peripheral neuropathy in …

Background Peripheral diabetic neuropathy (DN) is one of the major health problems facing
the whole world. There is no treatment that could completely reverse or prevent progression …

Background: Diabetes is one of the most common causes of peripheral neuropathy. There
are no known cures for diabetic neuropathy. Pentoxifylline could theoretically be a beneficial …

Metformin is the first line drug in the treatment of type 2 diabetes, however, little is known
about its therapeutic potential to prevent or delay damage to the peripheral nerve. Thus, the …